Two NEW prescription weight loss drugs, Qsymia and Belviq, have now been approved by the FDA.
Which, if either, is right for you?
Both drugs help some people lose weight. Neither drug is for everyone and the two drugs are quite different.
- Qsymia (kyoo-sim-EE-uh) is now available, but by mail order only. Qsymia, which is taken once a day, uses a one-two punch to spur weight loss. It combines low doses of topiramate, used to treat seizures and migraines, and phentermine, a currently available mild stimulant approved by the FDA for weight loss. Phentermine suppresses appetite soon after the pill is taken, and topiramate (which kicks in later in the day) creates a sense of feeling full. In the FDA reviewed clinical trials, Qsymia has been proven to help patients lose between 10% and 15% of their body weight over a year’s period as well as improve various cardiovascular aspects. Further studies have shown that this mixture has also had good results when studied as a sleep apnea treatment.
- Belviq (BEL-VEEK) works by targeting specific serotonin receptors in the brain linked with feelings of satiety, leading patients to feel full. The FDA has approved Belviq for adults who are obese or who are overweight and have at least one serious medical condition, such as diabetes or high cholesterol. The approved labeling for Belviq also recommends that people discontinue the drug if they fail to lose 5% of their body weight after 12 weeks as longer treatment is unlikely to lead to meaningful weight loss. Belviq is classified as a Schedule IV controlled substance, which means it has a low potential for abuse.
Express Clinic will be following these new drugs very closely. Please feel free to sign up for our newsletter for announcements.
We also carry other safe and effective FDA approved medications. If you’d like more information about our current program, call our clinic today.